References
- Anonīms (2008). Latvijas veselības statistikas gadagrāmata par 2007. gadu [Annual book of Latvian health statistics about 2007]. Veselības statistikas un medicīnas terminologiju agentūra, 2008 (in Latvian).
- Anonymous (2003). The European trial on reduction of cardiac events with perindopril in patients with stable coronary artery disease investgators. Efficacy of perindopril in reduction of cardiovascular events in stable coronary artery disease: Randomised, duble-blind, placebo controlled, multicentre trial (the EUROPA study). Lancet, 362, 782-788.
- Anonymous (2004). World Health Organization. http://apps.who.int/infobase/Comparisons.aspx
- Anonymous (2008). The BEAUTIFUL Study Group. The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction — baseline characteristics of the study population. Cardiology, 110, 271-282.
- Andrews, T.C., Fenton, T., Toyosaki, N., Glasser, S.P., Young, P.M., MacCallum, G., Gibson, R.S., Shook, T.L., Stone, P.H. (1993). The Angina and Silent Ischemia Study Group (ASIS). Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. Circulation, 88, 92-100.
- Aronow, W.S., Ahn, C., Mercando, A.D., Epstein, S. (1996). Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Amer. J. Cardiol., 78(10), 1175-1176.
- Benetos, A., Rudnichi, A., Thomas, F., Safar, M., Guize, L. (1999). Influence of heart rate on mortality in a French population: Role of age, gender and blood pressure. Hypertension, 33, 44-52.
- Boden, W.E., O'Rouke, R., Teo, K.T., Hartigan, P.M., Maron, D.J., Kostuk, W.I., Knudston, M., Dada, M., Casperson, P., Harris, C.L., Chaitman, B.R., Shaw, L., Gosselin, G., Navaz, S., Title, L.M. Gau, G., Blaustein A.S., Booth, D.C., Bates, E.R., Spertus, J.A., Berman, D.S., Mancini, J., Weintraub, W.S. for the COURAGE Trial Research Group. (2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New Engl. J. Med., 356. This article (10.1056/NEJMoa070829) was published at www.nejm.org on 27 March 2007. http://www.nejm.org
- Daly, C.A., Clemens, F., Lopez Sendon, J.L., Tavazzi, L., Boersma, E., Danchin, N., Delahaye, F., Gitt, A., Julian, D., Mulcahy, D., Ruzyllo, W., Thygesen, K., Verheugt, F., Fox, K.M. (2005). The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated with the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur. Heart J., 26, 1011-1022.
- Daly, C.A., De Stavola, B., Lopez-Sendon, J.L., Tavazzi, L., Boersma, E., Clemens, F., Danchin, N., Delahaye, F., Gitt, A., Julian, D., Mulcahy, D., Ruzyllo, W., Thygesen, K., Verheugt, F., Fox, K.M. (2006). Predicting prognosis in stable angina — results from the Euro Heart Survey of stable angina: Prospective observational study. BMJ, 332, 262-267.
- Daly, C., Tavazzi, L., Fox, K., Euro Heart Survey of Angina Investigators (2008). Inadequate control of heart rate in patients with stable angina: Results from the European Heart Survey. Eur. Heart J., 29 (Abstract Supplement), 204.
- Deedwania, P.C., Carbajal, E.V. (1992). Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life. Amer. J. Cardiol., 70, 19F-24F.
- Diaz, A., Bourassa, M.G., Guertin, M.C., Tardif, J.C. (2005). Long term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur. Heart J., 26(10), 967-974.
- Disegni, E., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E., Zion, M., Boyko, V., Behar, S. and the SPRINT study group (1995). The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J. Clin. Epidemiol., 48, 1197-1205.
- Ērglis, A., Kalvelis, A., Lejnieks, A., Dzērve, V., Latkovskis, G., Mintāle, I., Zakke, I., Rasa, I. (2007). Kardiovaskulāro slimību (KVS) profilakses vadlīnijas [Guidelines on cardiovascular disease prevention]. Rīga. 45. lpp. (in Latvian).
- Fox, K., Borer, J.S., Camm, A.J., Danchin, N., Ferrari, R., Sendon, J.L.L., Steg, P.G., Tardif, J.C., Tavazzi, L., Tendera, M., for a Heart Rate working Group (2007). Resting heart rate in cardiovascular disease. J. Amer. Coll. Cardiol., 50, 823-830.
- Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M., Ferrari R. (2008). Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet, 372(9641), 817-821.
- Futterman, L.G., Lemberg, L. (1999). Heart rate is a simplistic marker of mortality in acute myocardial infarction. Amer. J. Crit. Care, 8(3), 197-199.
- Gillman, M.W., Kannel, W.B., Belanger, A., D'Agostino, R.B. (1993). Influence of heart rate on mortality among persons with hypertension: The Framingham study. Amer. Heart J., 125(4), 1148-1154.
- Gislason, G.H., Rasmussen, J.N., Abildstrom, S.Z., Gadsboll, N., Buch, P., Friberg, J., Rasmussen, S., Kober, L., Stender, S., Madsen, M., Torp-Pederden, C. (2006). Long term compliance with beta-blockers, angiotensin-converting inhiitors, and statins after acute myocardial infarction. Eur. Heart J., 27, 1153-1158.
- Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., Gjelsvik, B., Herrmann-Lingen, C., Hoes, A., Humphries, S., Knapton, M., Perk, J., Priori, S.G., Pyorala, K., Reiner, Z., Ruilope, L., Sans-Menendez, S., Reimer, V.S.O., Weissberg, P., Wood, D., Yarnell, Y., Zamorano, J.L. (2007). European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur. Heart J., 28, 2375-2414.
- Hinderliter, A., Miller, P., Bragdon, E., Ballenger, M., Sheps, D. (1991). Myocardial ischemia during daily activities: The importance of increased oxygen demand. J. Amer. Coll. Cardiol., 18, 405-412.
- King, D.E., Everett, C.J., Mainous, A.G., Liszka, H.A. (2006). Long-term prognostic value of resting heart rate in subjects with prehypertension. Amer. J. Hypertens., 19(8), 796-800.
- Leal, J., Luengo-Fernįndez, R., Gray, A., Petersen, S., Rayner, M. (2006). Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J., 27(13), 1610-1619.
- Mathers, C.D., Loncar, D. (2006). Projections of global mortality and buren of disease from 2002 to 2030. PLoSMed., Nov, 3, e442.
- Menotti, A., Mulder, I., Nissinen, A., Giampaoli, S., Feskens, E.J., Kromhout, D. (2001) Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J. Clin. Epidemiol., 54, 680-686.
- Palatini, P., Benetos, A., Julius, S. (2006). Impact of increased heart rate on clinical outcomes in hypertension. Implications for antihypertensive drug therapy. Drugs, 66, 133-144.
- Palatini, P., Casiglia, E., Julius, S., Pessina, A.C. (1999). High heart rate: A risk factor for cardiovascular death in elderly men. Arch. Intern. Med., 159, 585-592.
- Palatini, P. (2005). Heart rate:Astrong predictor of mortality in subjects with coronary artery disease. Eur. Heart J., 26(10), 943-945.
- Panza, J.A., Diodati, J.G., Callahan, T.S., Epstein, S.E., Quyyumi, A.A. (1992). Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J. Amer. Coll. Cardiol., 20, 1092-1098.